Multikinase inhibitors

Lilly 3977 40 mg Pill - gray capsule-shape

Generic Name: selpercatinib

Pill with imprint Lilly 3977 40 mg is Gray, Capsule-shape and has been identified as Retevmo 40 mg. It is supplied by Eli Lilly and Company.

Retevmo is used in the treatment of Non-Small Cell Lung Cancer; Thyroid Cancer; Solid Tumors and belongs to the drug class multikinase inhibitors. Retevmo 40 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Retevmo (Selpercatinib)-Lilly 3977 40 mg-40 mg-Gray-Capsule-shape

Retevmo
Generic Name: selpercatinib
Imprint: Lilly 3977 40 mg
Strength: 40 mg
Color: Gray
Size: N/A
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Multikinase inhibitors
Pregnancy Category: N/A
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00002-3977
Inactive Ingredients:
Latest News
Related Drugs